373 results on '"Ben-Shoshan, Moshe"'
Search Results
2. Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
3. Patient-Reported Outcome Measures in Chronic Spontaneous Urticaria, Angioedema, and Atopic Dermatitis
4. Long-Term Adherence and Risk of Allergic Reactions in Patients Who Attained Milk Oral Immunotherapy Maintenance
5. Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials
6. Topical corticosteroids for hives and itch (urticaria): Systematic review and Bayesian meta-analysis of randomized trials
7. Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada
8. Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
9. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
10. Clinical characteristics and management of pediatric egg-induced anaphylaxis: A cross-sectional study
11. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice
12. Parental perceptions of a novel subsidy program to address the financial burden of milk allergy: a qualitative study
13. Early introduction is not enough: CSACI statement on the importance of ongoing regular ingestion as a means of food allergy prevention
14. Milk-induced anaphylaxis among children presenting to Canadian emergency departments
15. Management of anaphylaxis after pre-hospital epinephrine use in children with food-induced anaphylaxis
16. Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges
17. Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data
18. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
19. Prehospital epinephrine administration for treating anaphylaxis among those with comorbid asthma: A scoping review
20. “There's a chance we can overcome”: Parental perceptions on modified desensitization protocol for newly diagnosed toddlers
21. Impact of Reaction Setting on the Management, Severity, and Outcome of Pediatric Food-Induced Anaphylaxis: A Cross-Sectional Study
22. Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria
23. Tree nut-induced anaphylaxis in Canadian emergency departments: Rate, clinical characteristics, and management
24. Sesame-induced anaphylaxis in pediatric patients from the cross-Canada anaphylaxis registry
25. Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience
26. Economic burden of food allergy in Canada: Estimating costs and identifying determinants
27. vACcine COnfidence amongst those living with alleRgy during the COVID pandemic (ACCORD): a scoping review protocol
28. Seafood-induced anaphylaxis in children presenting to Canadian emergency departments: Rates, clinical presentation, and management
29. Pediatric Drug Allergy
30. Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience.
31. Prevalence, Management, and Anaphylaxis Risk of Cold Urticaria: A Systematic Review and Meta-Analysis
32. Elevated Cow’s Milk–Specific IgE Levels Prior to Oral Immunotherapy Decrease the Likelihood of Reaching the Maintenance Dose
33. Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines
34. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
35. Direct Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing
36. Fruit-Induced Anaphylaxis: Clinical Presentation and Management
37. Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis
38. An Approach to the Office-Based Practice of Food Oral Immunotherapy
39. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
40. Differentiating Between β-Lactam-Induced Serum Sickness–Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge
41. An investigation of a novel milk allergy-friendly food supplement program.
42. A scoping review protocol for evaluating cost questionnaires aimed at measuring the household financial burden of food allergy.
43. Evaluation of Prehospital Management in a Canadian Emergency Department Anaphylaxis Cohort
44. Adverse Events in Oral Immunotherapy for the Desensitization of Cow's Milk Allergy in Children: A Randomized Controlled Trial
45. Emergency Management of Anaphylaxis Due to an Unknown Trigger: An 8-Year Follow-Up Study in Canada
46. The Importance of Delabeling β-Lactam Allergy in Children
47. Międzynarodowe wytyczne EAACI/GA2LEN/EuroGuiDerm/ APAAACI dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki.
48. COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial.
49. Management of Pediatric Urticaria with Review of the Literature on Chronic Spontaneous Urticaria in Children
50. De-labeling of β-lactam allergy reduces intraoperative time and optimizes choice in antibiotic prophylaxis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.